MANCINI, GIORGIA
 Distribuzione geografica
Continente #
NA - Nord America 703
EU - Europa 325
AS - Asia 102
AF - Africa 14
Totale 1.144
Nazione #
US - Stati Uniti d'America 702
IT - Italia 117
SE - Svezia 49
CN - Cina 42
UA - Ucraina 41
IE - Irlanda 37
DE - Germania 22
SG - Singapore 22
TR - Turchia 21
DK - Danimarca 14
FR - Francia 14
GB - Regno Unito 14
CI - Costa d'Avorio 13
FI - Finlandia 10
KR - Corea 10
IN - India 6
BE - Belgio 2
CH - Svizzera 2
NL - Olanda 2
CA - Canada 1
JP - Giappone 1
NO - Norvegia 1
ZA - Sudafrica 1
Totale 1.144
Città #
Chandler 120
Des Moines 56
Fairfield 55
Ashburn 54
Jacksonville 45
New York 38
Dublin 37
Centro 30
Boardman 29
Wilmington 24
Houston 23
Seattle 23
Woodbridge 22
Cambridge 19
Marche 17
Redmond 17
Turin 16
Lawrence 15
Princeton 15
Abidjan 13
Ann Arbor 11
San Diego 11
San Mateo 10
Beijing 8
Guangzhou 7
Ancona 6
Los Angeles 6
Civitanova Marche 5
Menlo Park 5
Washington 5
London 4
Mumbai 4
Wuhan 4
Huskvarna 3
Porto 3
Singapore 3
Brussels 2
Fano 2
Gwangju 2
Kilburn 2
Milan 2
Norwalk 2
Palermo 2
Pune 2
Rome 2
Zurich 2
Brescia 1
Cedar Knolls 1
Chiaravalle 1
Chicago 1
Chiswick 1
Chizhou 1
Group 1
Helsinki 1
Hounslow 1
Jesi 1
Jiaxing 1
Jinan 1
Johannesburg 1
Kagoya 1
Leawood 1
Lequile 1
Macerata 1
Montreal 1
Nanjing 1
New Bedfont 1
Ningbo 1
Oslo 1
Palo Alto 1
Porto Torres 1
Portsmouth 1
Prescot 1
Quanzhou 1
Redwood City 1
Reggio Calabria 1
Shanghai 1
Shenzhen 1
Southwark 1
Termoli 1
Wuxi 1
Totale 817
Nome #
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 118
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 108
Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme 101
null 100
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 90
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 85
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 85
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 82
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 76
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 68
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 67
Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature 62
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 44
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 43
Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently 38
null 20
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria) 2
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 1
Totale 1.190
Categoria #
all - tutte 6.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202075 3 0 8 0 12 0 11 2 9 1 6 23
2020/2021199 17 19 20 0 22 7 33 21 22 14 13 11
2021/2022163 6 28 9 6 5 7 20 10 2 15 22 33
2022/2023350 30 44 16 23 25 85 0 16 63 2 38 8
2023/2024197 27 7 10 18 21 67 6 3 0 7 2 29
2024/202546 46 0 0 0 0 0 0 0 0 0 0 0
Totale 1.190